Catarina Azevedo

A team from the Institute for Research and Innovation in Health at the University of Porto (i3S), led by Salomé Pinho, has discovered a new strategy to make (CAR-)T cell therapies more effective against solid tumors. The findings were published in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR).

Uma equipa do Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S), liderada por Salomé Pinho, descobriu uma nova estratégia de tornar as terapias com células T (CAR-T) mais eficazes contra tumores sólidos. Os resultados foram publicados na revista Cancer Immunology Research, da American Association for Cancer Research(AACR).